Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-26

FDA Approved: ABACAVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Abacavir from Camber Pharmaceuticals, resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • abacavir (abacavir)

Snippet

SUPPL AP for ABACAVIR (ABACAVIR)